- AuthorisedTherapeutic exploratory (Phase II)
[68]GA-FAPI-46 PET/CT for the diagnosis of metastatic lesions in patients with lobular breast cancer (ICL). FAPICL
This study tests a new type of PET/CT scan for women with invasive lobular breast cancer. Standard scans can sometimes miss where this cancer has spread. Researchers want to see if a new imaging dye, called FAPI-46, can highlight hidden cancer cells that standard sugar-based scans fail to show.
For: invasive lobular carcinomas of the breastFrance - AuthorisedTherapeutic exploratory (Phase II)
68Ga-FAPI-46 PET for Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease
This study is looking at a new type of body scan (PET/CT) using a special tracer called 68Ga-FAPI-46. It aims to see how well this scan can help diagnose conditions like Giant Cell Arteritis and Polymyalgia Rheumatica, which cause inflammation in the body.
For: giant cell arteritis - polymyalgia rheumatica spectrum diseaseNetherlands - AuthorisedTherapeutic exploratory (Phase II)
Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases
This study looks at a new scanning method to find areas of scarring in people with certain long-term inflammatory conditions like Crohn's, ulcerative colitis, and some lung diseases. We want to see how this scan relates to markers in the body and help doctors understand these diseases better.
Netherlands - AuthorisedPhase I and Phase II (Integrated)- Other
The use of [68Ga]Ga-FAPI PET/MRI in assessing disease activity in patients with Graves’ orbitopathy
This study is looking at a new type of body scan (PET/MRI) for people with Graves' orbitopathy. It wants to see if this scan can show how active the eye condition is. This could help doctors understand your condition better.
For: Graves' OrbitopathyNetherlands